Annual report pursuant to Section 13 and 15(d)

Note 21 - Segment Information: Reconciliation of Revenue from Segments to Consolidated (Tables)

v3.21.1
Note 21 - Segment Information: Reconciliation of Revenue from Segments to Consolidated (Tables)
12 Months Ended
Dec. 31, 2020
Tables/Schedules  
Reconciliation of Revenue from Segments to Consolidated

 

 

 

2020

 

2019

Operating loss

$

(1,074,104)

$

(1,745,943)

Realized gain (loss) on investments in securities

 

(14,961)

 

(78,649)

Gain on sale of GlauCanna rights

 

31,000

 

-

Impairment of investments

 

(139,148)

 

(1,688,825)

Interest income

 

92,571

 

108,113

Interest expense

 

(35,295)

 

(22,596)

Gain (loss) on equipment disposals

 

67

 

2,200

PPP loan forgiven

 

452,348

 

-

EIDL Grant

 

10,000

 

-

Other income

 

10,031

 

21,896

Income before income taxes

$

(667,491)

$

(3,403,804)